MedPath

Effect of combined omega-3 and vitamin D supplementation in treatment of multiple sclerosis

Phase 2
Conditions
Multiple Sclerosis.
Demyelinating disease of the central nervous system
Registration Number
IRCT2017090133941N20
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with multiple sclerosis
Aged 18-55 years
Course of disease relapsing–remitting MS (RRMS)
EDSS =4.5

Exclusion Criteria

Pregnancy
Lactating during the past 6 month
History of nephrolithiasis during the previous5 y
No regular menstruation
Menopause
Unwillingnessto use appropriate contraception

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath